ES476049A1 - Procedimiento para la preparacion de acilanilidas. - Google Patents

Procedimiento para la preparacion de acilanilidas.

Info

Publication number
ES476049A1
ES476049A1 ES476049A ES476049A ES476049A1 ES 476049 A1 ES476049 A1 ES 476049A1 ES 476049 A ES476049 A ES 476049A ES 476049 A ES476049 A ES 476049A ES 476049 A1 ES476049 A1 ES 476049A1
Authority
ES
Spain
Prior art keywords
carbon atoms
pharmaceutical
manufacture
compositions containing
amide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476049A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES476049A1 publication Critical patent/ES476049A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/115—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B31/00—Associated working of cameras or projectors with sound-recording or sound-reproducing means
    • G03B31/02—Associated working of cameras or projectors with sound-recording or sound-reproducing means in which sound track is on a moving-picture film

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES476049A 1977-12-15 1978-12-15 Procedimiento para la preparacion de acilanilidas. Expired ES476049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5222377 1977-12-15

Publications (1)

Publication Number Publication Date
ES476049A1 true ES476049A1 (es) 1979-05-16

Family

ID=10463104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476049A Expired ES476049A1 (es) 1977-12-15 1978-12-15 Procedimiento para la preparacion de acilanilidas.

Country Status (21)

Country Link
US (1) US4191775A (Sortimente)
EP (1) EP0002892B1 (Sortimente)
JP (1) JPS5495519A (Sortimente)
AT (1) AT360974B (Sortimente)
AU (1) AU522716B2 (Sortimente)
BG (1) BG31225A3 (Sortimente)
CA (1) CA1123008A (Sortimente)
CS (1) CS208112B2 (Sortimente)
DD (1) DD139844A5 (Sortimente)
DE (1) DE2862459D1 (Sortimente)
DK (1) DK556978A (Sortimente)
ES (1) ES476049A1 (Sortimente)
FI (1) FI70007C (Sortimente)
HU (1) HU176981B (Sortimente)
IE (1) IE49866B1 (Sortimente)
IL (1) IL56155A (Sortimente)
IT (1) IT1107675B (Sortimente)
NO (1) NO149035C (Sortimente)
NZ (1) NZ189086A (Sortimente)
PT (1) PT68922A (Sortimente)
ZA (1) ZA786781B (Sortimente)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197008A (en) * 1980-05-22 1984-10-19 Ici Ltd Acylanilide derivatives and pharmaceutical compositions
AU8961382A (en) * 1981-11-06 1983-05-12 Imperial Chemical Industries Plc Amide derivatives
US5236953A (en) * 1982-04-14 1993-08-17 Imperial Chemical Industries Plc Alkene, alkyne or cycloalkylene derivatives
GB8504093D0 (en) * 1985-02-18 1985-03-20 Ici Plc Alkene alkyne/cycloalkylene derivatives
LU88769I2 (fr) * 1982-07-23 1996-11-05 Zeneca Ltd Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
GB8406000D0 (en) * 1984-03-07 1984-04-11 Ici Plc Olefine derivatives
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
JP2585087B2 (ja) * 1987-05-22 1997-02-26 ブラッコ インターナショナル ベ ヴェ ５‐アシルアミノ‐２，４，６‐トリヨード‐または‐トリブロモ‐ベンゾイックアシッド誘導体の製造方法およびその製造方法によって得られる新規の５‐アシルアミノ‐２，４，６‐トリヨードまたは‐トリブロモ‐ベンゾイックアシッド誘導体
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
AU670554B2 (en) * 1991-11-05 1996-07-25 Gillette Company, The Alteration of rate and character of hair growth
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
GB9305295D0 (en) * 1993-03-15 1993-05-05 Zeneca Ltd Therapeutic compounds
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6248751B1 (en) 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
US6414017B2 (en) 1993-05-28 2002-07-02 The Gillette Company Inhibition of hair growth
JPH0759644A (ja) * 1993-08-24 1995-03-07 Nobuyuki Yamamoto 納骨用仏像
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
DE69529665T2 (de) * 1994-06-27 2004-02-19 Neutron Therapies Inc., San Diego Bor enthaltende hormonanaloga und verfahren fuer ihre verwendung zur bildlichen darstellung oder zum abtoeten von zellen, die hormonrezeptoren besitzen
US5554608A (en) * 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
ES2175084T3 (es) * 1995-02-28 2002-11-16 Gillette Co Uso de supresores de angiogenesis para inhibir el crecimiento del pelo.
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5728736A (en) * 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
FR2747039B1 (fr) * 1996-04-05 1998-05-22 Oreal Utilisation du n-(3,4-dicyano-phenyl)- 3,3,3-trifluoro- 2-hydroxy-2-methylpropionamide pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
AU2030397A (en) * 1996-03-06 1997-09-22 L'oreal Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
FR2745717B1 (fr) * 1996-03-06 1998-04-17 Oreal Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
US5840752A (en) * 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US20050038110A1 (en) * 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US7759520B2 (en) * 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US7518013B2 (en) * 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) * 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6245804B1 (en) 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
AU7604798A (en) * 1997-05-30 1998-12-30 University Of Tennessee Research Corporation, The Non-steroidal agonist compounds and their use in male hormone therapy
AU7723198A (en) * 1997-06-04 1998-12-21 University Of Tennessee Research Corporation, The Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US5939458A (en) * 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6060471A (en) * 1998-01-21 2000-05-09 Styczynski; Peter Reduction of hair growth
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
US20040176470A1 (en) * 1998-05-07 2004-09-09 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
US6020006A (en) * 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6184249B1 (en) * 1998-12-18 2001-02-06 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
US6121269A (en) * 1999-02-22 2000-09-19 Henry; James P. Reduction of hair growth
HUP0202725A3 (en) 1999-09-04 2005-04-28 Astrazeneca Ab Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity, process for their preparation and pharmaceutical compositions containing them
JP2003508514A (ja) 1999-09-04 2003-03-04 アストラゼネカ アクチボラグ 化学的化合物
ES2307528T3 (es) 1999-09-04 2008-12-01 Astrazeneca Ab Amidas como inhibidores para la piruvato deshidrogenasa.
US6235737B1 (en) * 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
AU2001288213B2 (en) 2000-06-28 2005-04-14 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2001277731A1 (en) 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US6998500B2 (en) * 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
IL154425A0 (en) 2000-08-24 2003-09-17 Univ Tennessee Res H Corp Selective androgen receptor modulators and methods of use thereof
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7919647B2 (en) * 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) * 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
ATE344233T1 (de) 2000-08-24 2006-11-15 Univ Tennessee Res Corp Selektive modulatoren des andro genrezeptors und methoden zu deren verwendung
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
DE10051981A1 (de) 2000-10-20 2002-05-02 Bayer Ag Substituierte Phenyluracile
US20040131574A1 (en) * 2001-02-07 2004-07-08 Bergeron Raymond J Method and composition for the control of hair growth
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
DK1463497T3 (da) * 2001-12-06 2012-01-30 Gtx Inc Behandling af muskelsvind med selektive androgenreceptormodulatorer
EP1462442B1 (en) 2001-12-13 2009-08-26 Sumitomo Chemical Company, Limited Crystals of bicalutamide and process for their production
AU2002364082A1 (en) * 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
JP4677516B2 (ja) * 2002-02-07 2011-04-27 ユニバーシティ オブ テネシー リサーチ ファウンデーション Ｓａｒｍを用いた前立腺肥大症治療
AU2003217304A1 (en) * 2002-02-28 2003-09-16 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
JP5113979B2 (ja) * 2002-02-28 2013-01-09 ユニバーシティ オブ テネシー リサーチ ファウンデーション 複数置換の選択的アンドロゲンレセプタ修飾因子及びその使用方法
CN1639110A (zh) * 2002-02-28 2005-07-13 田纳西大学研究基金会 卤代乙酰胺和叠氮化物取代的化合物及其使用方法
US7772433B2 (en) * 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
US7803970B2 (en) * 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7022870B2 (en) * 2002-06-17 2006-04-04 University Of Tennessee Research Foundation N-bridged selective androgen receptor modulators and methods of use thereof
US7741371B2 (en) * 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US20040224979A1 (en) * 2002-10-15 2004-11-11 Dalton James T. Treating obesity with selective androgen receptor modulators
JP2006506369A (ja) * 2002-10-15 2006-02-23 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション メチレン架橋選択的アンドロゲン受容体調節剤及びその使用方法
US20040197928A1 (en) * 2002-10-15 2004-10-07 Dalton James T. Method for detecting selective androgen receptor modulators
CA2501874A1 (en) * 2002-10-16 2004-04-29 Gtx, Inc. Treating androgen decline in aging male (adam)-associated conditions with sarms
US20060276539A1 (en) * 2002-10-16 2006-12-07 Dalton James T Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
US20040087810A1 (en) * 2002-10-23 2004-05-06 Dalton James T. Irreversible selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US20040167103A1 (en) * 2003-02-24 2004-08-26 Dalton James T. Haloacetamide and azide substituted compounds and methods of use thereof
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
EA200501761A1 (ru) * 2003-12-16 2006-04-28 Джи Ти Икс, ИНК. Пролекарственные формы селективных модуляторов андрогеновых рецепторов и способы их применения
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US20060258628A1 (en) * 2004-07-20 2006-11-16 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
EP1827280A2 (en) * 2004-12-22 2007-09-05 The Gillette Company Reduction of hair growth
CA2589762A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth with survivin inhibitors
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
EP3056483A1 (en) 2006-08-24 2016-08-17 University of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
WO2013152170A1 (en) 2012-04-04 2013-10-10 Catylix, Inc. Selective androgen receptor modulators
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
HUE052574T2 (hu) 2012-07-13 2021-05-28 Oncternal Therapeutics Inc Eljárás mellrákok kezelésére szelektív ösztrogén receptor modulátorral (SARM)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995060A (en) * 1972-06-20 1976-11-30 Schering Corporation Antiandrogenic agents and method for the treatment of androgen dependent disease states
DE1793110A1 (de) * 1968-08-02 1971-12-16 Basf Ag Substituierte Saeureanilide
DE2042300A1 (de) * 1970-08-26 1972-03-23 Farbwerke Hoechst AG, vormals Meister Lucius & Brüning, 6000 Frankfurt Halogencarbonsäureanilide, ihre Herstellung und Verwendung als Herbizide
CA1012462A (en) * 1971-06-18 1977-06-21 Scherico Ltd. Pharmaceutical composition containing substituted anilides
US3875229A (en) * 1972-11-24 1975-04-01 Schering Corp Substituted carboxanilides
JPS6044294B2 (ja) * 1976-04-15 1985-10-02 帝国臓器製薬株式会社 アニリド誘導体

Also Published As

Publication number Publication date
BG31225A3 (bg) 1981-11-16
AT360974B (de) 1981-02-10
AU522716B2 (en) 1982-06-24
ATA874278A (de) 1980-07-15
FI783820A7 (fi) 1979-06-16
DD139844A5 (de) 1980-01-23
JPS5495519A (en) 1979-07-28
DE2862459D1 (en) 1985-03-21
NO149035B (no) 1983-10-24
IL56155A (en) 1982-09-30
NZ189086A (en) 1980-09-12
EP0002892A1 (en) 1979-07-11
CA1123008A (en) 1982-05-04
NO149035C (no) 1984-02-01
US4191775A (en) 1980-03-04
PT68922A (en) 1979-01-01
IT7852280A0 (it) 1978-12-13
DK556978A (da) 1979-06-16
IE49866B1 (en) 1986-01-08
EP0002892B1 (en) 1985-02-06
IT1107675B (it) 1985-11-25
JPH0223537B2 (Sortimente) 1990-05-24
IL56155A0 (en) 1979-03-12
CS208112B2 (en) 1981-08-31
NO784211L (no) 1979-06-18
FI70007C (fi) 1986-09-12
AU4220078A (en) 1979-06-21
HU176981B (hu) 1981-06-28
FI70007B (fi) 1986-01-31
ZA786781B (en) 1979-11-28

Similar Documents

Publication Publication Date Title
ES476049A1 (es) Procedimiento para la preparacion de acilanilidas.
ES477008A1 (es) Procedimiento para la preparacion de difenileteres.
ES391026A1 (es) Procedimiento para la obtencion de benzonaftiridina.
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
ES8705411A1 (es) Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES465225A1 (es) Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2).
ES450799A1 (es) Un procedimiento para la preparacion de nuevas 3-fenilespino(esobenzofuran-1,4'-piperidemo) sulfenamidas y derivados.
ES390163A1 (es) Procedimiento para la preparacion de amino-derivados de los acidos pirazolo (3,4-b) piridina-5-carboxilicos.
SE7503868L (sv) Forfarande for framstellning av bensobicyklonenderivat.
ES436317A1 (es) Procedimiento para la preparacion de nuevas isoquinoleinas.
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
ES419019A1 (es) Procedimiento para la preparacion de compuestos polici- clicos.
ES8601138A1 (es) Un procedimiento para preparar derivados de 5-(piridinil o fenil)-2(1h)-piridinona
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ES446325A1 (es) Procedimiento para preparar tieno-(3,2-c)-piridina y deriva-dos de la misma.
ES374087A1 (es) Un procedimiento para la preparacion de agentes antibacte- rianos.
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
SE8402361L (sv) Nya acylaminofenolderivat
EP0030620A3 (en) Substituted 2-phenylamino-2-imidazolines, acid addition salts thereof, medicaments containing them and process for preparing them
SE7607818L (sv) Sett att framstella nya fenoxialkylaminpyridyletrar
ES437262A1 (es) Procedimiento para la preparacion de nuevas 6-aril-4h-s- triazolo-(3, 4c)-tieno-(2, 3e)-1, 4-diazepinas sustituidas.
ES395953A1 (es) Un procedimiento para la preparacion de 2-(p-fenilbencil)- oxazolinas.
IL70272A (en) Acridanone(2-thiazolyl)-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
GB1036272A (en) Tertiary aryloxyalkanoyl aminoalkylamines
ES2052945T3 (es) Derivados de la 20,21-dinoreburnamenina sustituidos en 15 con un grupo aminado y sus sales, su procedimiento de preparacion y los productos intermedios asi obtenidos, su aplicacion como medicamentos, y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19870224